0,829  0,005  Antineoplastic (colorectal cancer)
0,821  0,008  Caspase 9 stimulant
0,817  0,006  Antineoplastic (colon cancer)
0,760  0,005  Prostate cancer treatment
0,731  0,015  Antineoplastic (lung cancer)
0,715  0,004  Antineoplastic (renal cancer)
0,696  0,005  Antineoplastic (non-small cell lung cancer)
0,707  0,020  Antineoplastic (breast cancer)
0,659  0,008  Antineoplastic (melanoma)
0,658  0,011  Antineoplastic (ovarian cancer)
0,658  0,038  Apoptosis agonist
0,595  0,009  CYP2C19 inhibitor
0,582  0,006  Antineoplastic (glioblastoma multiforme)
0,582  0,008  Antiprotozoal (Trypanosoma)
0,567  0,011  Antineoplastic (glioma)
0,565  0,018  5 Hydroxytryptamine release stimulant
0,542  0,027  Antiprotozoal
0,525  0,020  Antineoplastic (cervical cancer)
0,518  0,015  Antiprotozoal (Leishmania)
0,515  0,018  Caspase 3 stimulant
0,489  0,007  Antineoplastic (squamous cell carcinoma)
0,468  0,010  Antineoplastic (carcinoma)
0,489  0,059  Antineoplastic (solid tumors)
0,438  0,010  Tubulin antagonist
0,442  0,025  CYP2D6 inhibitor
0,418  0,013  Muscle relaxant
0,438  0,039  Antiprotozoal (Plasmodium)
0,426  0,028  Antineoplastic (multiple myeloma)
0,422  0,034  Antiischemic
0,417  0,058  Antileukemic
0,386  0,029  Antineoplastic (lymphoma)
0,385  0,035  Cytostatic
0,385  0,036  CYP3A4 inhibitor
0,360  0,015  Male reproductive disfunction treatment
0,351  0,010  Erectile dysfunction treatment
0,341  0,009  Toxic, respiratory center
0,359  0,027  Antineoplastic (lymphocytic leukemia)
0,360  0,049  CYP1A2 substrate
0,319  0,009  Topoisomerase I inhibitor
0,325  0,028  Sedative
0,310  0,020  Skeletal muscle relaxant
0,313  0,036  Antineoplastic (sarcoma)
0,310  0,041  Antimitotic
0,267  0,014  CDC-like kinase 1 inhibitor
0,312  0,064  Antineoplastic (small cell lung cancer)
0,267  0,022  Topoisomerase II inhibitor
0,288  0,060  NOS2 expression inhibitor
0,271  0,043  ErbB-1 antagonist
0,293  0,069  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,286  0,068  UGT2B4 substrate
0,257  0,041  Hepatoprotectant
0,255  0,042  Myocardial ischemia treatment
0,294  0,084  Antineoplastic (brain cancer)
0,228  0,019  DNA intercalator
0,213  0,006  CDC-like kinase 3 inhibitor
0,262  0,058  Cyclic AMP phosphodiesterase inhibitor
0,320  0,117  TNF expression inhibitor
0,244  0,042  Neurotrophic factor enhancer
0,289  0,087  Hepatic disorders treatment
0,277  0,078  Antineoplastic (pancreatic cancer)
0,262  0,064  Cardiodepressant
0,222  0,025  Carcinogenic, group 1
0,209  0,011  Antineoplastic alkaloid
0,232  0,046  Antianginal
0,195  0,018  Alcohol dehydrogenase substrate
0,299  0,133  15-Lipoxygenase inhibitor
0,209  0,047  LDLR expression enhancer
0,164  0,008  Phosphodiesterase XI inhibitor
0,164  0,008  Phosphodiesterase 11A inhibitor
0,222  0,066  VCAM1 expression inhibitor
0,258  0,102  CYP2D6 substrate
0,162  0,008  Alpha tubulin antagonist
0,165  0,016  Phosphodiesterase 4D inhibitor
0,192  0,043  UGT2B10 substrate
0,155  0,013  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,208  0,071  Antiarrhythmic
0,156  0,021  Calcium antagonist
0,177  0,041  Acetylcholinesterase inhibitor
0,223  0,098  DNA damaging
0,216  0,092  Vasodilator
0,205  0,083  Antiparkinsonian, rigidity relieving
0,135  0,014  Beta tubulin antagonist
0,234  0,115  Hypoxia-inducible factor 1 alpha inhibitor
0,213  0,096  Antineoplastic (liver cancer)
0,138  0,025  Topoisomerase II alpha inhibitor
0,159  0,047  MAP3K9 inhibitor
0,210  0,100  Antipyretic
0,176  0,068  Antineoplastic (bone cancer)
0,138  0,031  Alpha 2 adrenoreceptor antagonist
0,130  0,036  Electron transport complex I inhibitor
0,161  0,070  Antimutagenic
0,232  0,142  Vasodilator, peripheral
0,209  0,121  Antineoplastic (bladder cancer)
0,162  0,074  Prostate disorders treatment
0,211  0,123  CYP1A2 inhibitor
0,206  0,120  UGT1A9 substrate
0,185  0,103  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,093  0,012  Potassium channel (Ca-activated) blocker
0,180  0,099  Antihypertriglyceridemic
0,247  0,167  CYP2C9 inhibitor
0,156  0,081  Sigma receptor agonist
0,101  0,027  Phosphodiesterase V inhibitor
0,220  0,150  Transcription factor NF kappa B inhibitor
0,075  0,005  Melatonin antagonist
0,165  0,096  P-glycoprotein inhibitor
0,088  0,019  Glutamate (mGluR7) antagonist
0,103  0,035  ATPase (Vacuolar H+) inhibitor
0,128  0,061  Alkylator
0,144  0,078  Antiischemic, cerebral
0,166  0,103  Abortion inducer
0,144  0,082  Cholinergic
0,190  0,129  Spasmolytic
0,075  0,015  Bcl-xL inhibitor
0,066  0,013  Factor III inhibitor
0,087  0,034  Phosphodiesterase 5A inhibitor
0,058  0,005  Melatonin 1 antagonist
0,192  0,140  5 Hydroxytryptamine 1E antagonist
0,185  0,134  Cardiotonic
0,123  0,074  Papain-like protease (SARS coronavirus) inhibitor
0,056  0,009  Endothelin receptor antagonist
0,156  0,110  Pyruvate kinase inhibitor
0,082  0,037  Antitreponemal
0,172  0,128  5 Hydroxytryptamine 3E antagonist
0,058  0,015  Premature ejaculation treatment
0,159  0,117  CYP2B6 inhibitor
0,133  0,091  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,077  0,035  Dopamine D1 antagonist
0,132  0,090  Genotoxic
0,118  0,077  DNA repair enzyme inhibitor
0,152  0,112  Clk dual-specificity kinase inhibitor
0,097  0,058  Breast cancer-resistant protein inhibitor
0,146  0,108  ATPase inhibitor
0,083  0,046  Alpha 2a adrenoreceptor antagonist
0,162  0,125  Dyrk kinase inhibitor
0,042  0,006  Endothelin B receptor antagonist
0,086  0,053  Antineoplastic antibiotic
0,165  0,132  UGT1A6 substrate
0,051  0,019  Phosphodiesterase 6C inhibitor
0,095  0,063  Phosphodiesterase 6D inhibitor
0,135  0,104  Melanin inhibitor
0,188  0,159  Tyrosine 3 hydroxylase inhibitor
0,118  0,090  Antineoplastic (uterine cancer)
0,179  0,152  Proliferative diseases treatment
0,158  0,131  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,136  0,110  Nitric oxide antagonist
0,094  0,068  Dementia treatment
0,060  0,034  Protein kinase C eta inhibitor
0,156  0,131  Pneumotoxic
0,091  0,067  Vascular dementia treatment
0,179  0,155  DNA synthesis inhibitor
0,127  0,104  UGT1A3 substrate
0,082  0,060  Carcinogenic, group 2A
0,038  0,017  Melatonin 2 agonist
0,056  0,035  Protein kinase C epsilon inhibitor
0,135  0,115  Cytotoxic
0,030  0,010  Endothelin A receptor antagonist
0,132  0,112  Carcinogenic
0,086  0,068  Protein kinase C delta inhibitor
0,066  0,048  Female sexual dysfunction treatment
0,050  0,033  Topoisomerase II beta inhibitor
0,033  0,017  Phosphodiesterase 6B inhibitor
0,065  0,052  Protein kinase C alpha inhibitor
0,089  0,079  UGT2B11 substrate
0,024  0,015  Phosphodiesterase 6G inhibitor
0,024  0,015  Phosphodiesterase 6H inhibitor
0,153  0,143  Antihypercholesterolemic
0,070  0,062  Phosphodiesterase VI inhibitor
0,085  0,076  Butyrylcholinesterase inhibitor
0,072  0,070  Phosphodiesterase IV inhibitor
0,035  0,033  Vesicle monoamine transporter inhibitor
0,013  0,010  Melatonin receptor 1A antagonist
0,098  0,095  Microtubule formation inhibitor
0,177  0,175  Prostaglandin dehydrogenase inhibitor
0,098  0,097  Aldehyde dehydrogenase substrate
0,096  0,095  Activin receptor-like kinase 4 inhibitor
0,029  0,029  Melatonin agonist

